S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Novo Nordisk Arms Wegovy to Be a Triple Threat
Stock market today: Global markets are mixed as Middle East tensions escalate
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market

POINT Biopharma Global (PNT) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
bloomberg.com logoInvesting in biopharma innovation: Can you stay one step ahead?
bloomberg.com - April 8 at 8:10 PM
businesswire.com logoDomain Therapeutics Strengthens Leadership Team to Spearhead Global Development and North American Expansion as the Leading GPCR Immuno-Oncology Company
businesswire.com - January 8 at 2:32 PM
finance.yahoo.com logoLilly Completes Acquisition of POINT Biopharma
finance.yahoo.com - December 27 at 9:30 AM
marketbeat.com logo
marketbeat.com - December 27 at 6:01 AM
markets.businessinsider.com logoPOINT Biopharma Global Rating Adjustment: Hold Recommendation Following Shareholder Dynamics and Acquisition Prospects
markets.businessinsider.com - December 22 at 8:49 AM
msn.com logoBrookline Capital Downgrades POINT Biopharma Global (PNT)
msn.com - December 22 at 8:49 AM
benzinga.com logoPOINT Biopharma Global Stock (NASDAQ:PNT), Guidance and Forecast
benzinga.com - December 22 at 12:13 AM
marketbeat.com logoPOINT Biopharma Global (NASDAQ:PNT) Receives Hold Rating from Brookline Capital Management
marketbeat.com - December 21 at 8:22 AM
msn.com logoLilly extends tender offer for POINT Biopharma to Dec. 22
msn.com - December 18 at 3:32 PM
seekingalpha.com logoWhy POINT Biopharma Global Is At Least A Hold On Disappointing Readout
seekingalpha.com - December 18 at 3:32 PM
marketbeat.com logoPOINT Biopharma Global Sees Unusually High Options Volume (NASDAQ:PNT)
marketbeat.com - December 18 at 1:39 PM
markets.businessinsider.com logoLantheus Holdings And POINT Biopharma Announced Lu-PNT2002 Phase 3 SPLASH Study Results
markets.businessinsider.com - December 18 at 10:32 AM
marketbeat.com logoPOINT Biopharma Global Inc. (NASDAQ:PNT) Short Interest Down 28.1% in November
marketbeat.com - December 14 at 10:39 PM
marketbeat.com logoStock Traders Buy Large Volume of Put Options on POINT Biopharma Global (NASDAQ:PNT)
marketbeat.com - December 13 at 3:48 PM
msn.com logoPOINT Biopharma Global Inc. (PNT) Upgraded to Buy: Here's What You Should Know
msn.com - December 8 at 6:24 PM
markets.businessinsider.com logoLilly Says Tender Offer Expiration Extended Related To POINT Biopharma Acquisition
markets.businessinsider.com - December 4 at 10:26 AM
marketbeat.com logo
marketbeat.com - December 4 at 6:11 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: POINT Biopharma Global (PNT), Regeneron (REGN) and Incyte (INCY)
markets.businessinsider.com - November 30 at 7:53 PM
markets.businessinsider.com logoHold Rating on POINT Biopharma Global: An Assessment of Acquisition Offer, Pipeline Updates, and Financial Stability
markets.businessinsider.com - November 17 at 11:33 AM
finance.yahoo.com logoLilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023
finance.yahoo.com - November 17 at 11:33 AM
marketbeat.com logo
marketbeat.com - November 17 at 6:03 AM
benzinga.com logoPOINT Biopharma Global Stock (NASDAQ:PNT) Earnings Dates and Earning Calls
benzinga.com - November 15 at 12:37 AM
markets.businessinsider.com logoLilly Receives NRC Consent In Connection With Proposed Acquisition Of POINT Biopharma
markets.businessinsider.com - November 15 at 12:37 AM
markets.businessinsider.com logoPiper Sandler Keeps Their Hold Rating on POINT Biopharma Global (PNT)
markets.businessinsider.com - November 15 at 12:37 AM
benzinga.com logoPOINT Biopharma Global (PNT) News: Johnson Fistel Investigates Proposed Sale; Is $12.50 a Fair Price?
benzinga.com - November 14 at 2:34 PM
seekingalpha.com logoPOINT Biopharma Global: Why The Market Believes That A Second Bidder May Emerge
seekingalpha.com - November 14 at 2:11 AM
benzinga.com logoRecap: POINT Biopharma Global Q3 Earnings
benzinga.com - November 13 at 2:12 PM
markets.businessinsider.com logoPOINT Biopharma Reports Loss In Q3, Flat With Last Year, A Week After Lilly Agreed To Acquire It
markets.businessinsider.com - November 13 at 2:12 PM
finance.yahoo.com logoPOINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
finance.yahoo.com - November 13 at 7:39 AM
msn.com logoEli Lilly extends expiration of tender offer to acquire Point Biopharma
msn.com - November 8 at 11:38 PM
markets.businessinsider.com logoLilly Extends Tender Offer For POINT Biopharma Global Until Nov. 16
markets.businessinsider.com - November 8 at 11:38 PM
finance.yahoo.com logoLilly Announces Extension of Tender Offer to Acquire POINT Biopharma
finance.yahoo.com - November 8 at 6:37 PM
msn.com logoPoint Biopharma quickly gains as big holder comes out against Eli Lilly deal
msn.com - November 6 at 3:26 PM
markets.businessinsider.com logoHold Rating on POINT Biopharma Global: Prospects, Uncertainties, and Potential of PNT2002
markets.businessinsider.com - October 26 at 6:33 PM
msn.com logoPiper Sandler Downgrades POINT Biopharma Global (PNT)
msn.com - October 24 at 11:37 PM
barrons.com logoSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of POINT Biopharma Global, Inc. (PNT)
barrons.com - October 19 at 7:36 PM
msn.com logoPOINT Biopharma trades through deal price with Eli Lilly
msn.com - October 18 at 5:06 PM
markets.businessinsider.com logoHold Rating on POINT Biopharma Amid Acquisition Proposal Uncertainties and Potential Risks
markets.businessinsider.com - October 18 at 12:06 PM
msn.com logoRaymond James Downgrades POINT Biopharma Global (PNT)
msn.com - October 7 at 3:30 AM
businesswire.com logoPOINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT ...
businesswire.com - October 6 at 9:05 PM
reuters.com logoLilly eyes targeted cancer therapies with $1.4 billion Point Biopharma deal
reuters.com - October 5 at 4:23 PM
markets.businessinsider.com logoLilly To Acquire POINT Biopharma For $1.4 Bln In Cash; POINT Up In Pre Market
markets.businessinsider.com - October 3 at 5:00 PM
markets.businessinsider.com logoCrude Oil Moves Higher; POINT Biopharma Global Shares Jump
markets.businessinsider.com - October 3 at 5:00 PM
finance.yahoo.com logoCruise lines, spinoff slumps, Eli Lilly-Point deal: Trending Stocks
finance.yahoo.com - October 3 at 5:00 PM
seekingalpha.com logoEli Lilly POINTs Toward Radiopharmaceutical Ambitions
seekingalpha.com - October 3 at 1:32 PM
finanznachrichten.de logoEli Lilly and Company: Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies
finanznachrichten.de - October 3 at 12:00 PM
seekingalpha.com logoEli Lilly to acquire Point Biopharma in $1.4B deal
seekingalpha.com - October 3 at 12:00 PM
benzinga.com logoShareholder Alert: Ademi LLP investigates whether POINT Biopharma Global, Inc. has obtained a Fair Price in its transaction with Eli Lilly
benzinga.com - October 3 at 12:00 PM
finance.yahoo.com logoLilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies
finance.yahoo.com - October 3 at 7:00 AM
finance.yahoo.com logoWill Weakness in POINT Biopharma Global Inc.'s (NASDAQ:PNT) Stock Prove Temporary Given Strong Fundamentals?
finance.yahoo.com - September 30 at 1:28 PM
Get POINT Biopharma Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNT and its competitors with MarketBeat's FREE daily newsletter.

Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

PNT Media Mentions By Week

PNT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PNT
News Sentiment

0.00

0.64

Average
Medical
News Sentiment

PNT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PNT Articles
This Week

1

1

PNT Articles
Average Week

Get POINT Biopharma Global News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:PNT) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners